CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology Biological Versus Chronological Aging: JACC Focus Seminar Adenosine and adenosine receptor-mediated action in coronary microcirculation

Original ResearchMay 11,2024

JOURNAL:Lancet Article Link

Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

葛震、阚静、高晓飞、陈绍良、Gregg W. Stone

Full Text PDF